Domain Therapeutics Grants Prexton Therapeutics an Exclusive Option to License and Develop mGluR4 PAMs for Parkinson's Disease
1/22/2013 11:20:58 AM
More...
|
Domain Therapeutics Enters Into Collaboration Agreement With Ono Pharmaceutical Company, Ltd. in the Field of GPCR-Based Drug Discovery
10/23/2012 9:47:01 AM
More...
|
Domain Therapeutics Closes EUR Two Million Funding Round
7/17/2012 12:08:56 PM
More...
|
Domain Therapeutics Wins EUR 933,000 Grant for Schizophrenia Project
3/13/2012 9:27:59 AM
More...
|
Domain Therapeutics Awarded Grant from The Michael J. Fox Foundation for the Development of Novel mGluR3 PAM Compounds to Treat Parkinson's Disease
1/30/2012 11:32:55 AM
More...
|
Domain Therapeutics and Merck Serono Announce $178M Agreement to Develop Drugs for Parkinson's Disease
1/18/2011 12:14:33 PM
More...
|
Domain Therapeutics Fuels Pipeline With $2.9M
12/16/2008 8:46:38 AM
More...
|